Literature DB >> 36048305

Three-Dimensional Echocardiography for Tricuspid Valve Assessment.

Claudia Escabia1, Antoni Bayes-Genis1, Victoria Delgado2,3.   

Abstract

PURPOSE OF REVIEW: This review article provides an overview of the various roles of 3-dimensional (3D) echocardiography in the evaluation of the tricuspid valve (TV) with specific focus on tricuspid regurgitation (TR) and its treatment. RECENT
FINDINGS: The prognostic implications of TR and the advent of new transcatheter therapies have underscored the need of accurate assessment of the TV. 3D echocardiography is key to assess the anatomy and function of TV and has provided new insights that have led to new classifications of the type of TR. Furthermore, 3D echocardiography is superior to 2-dimensional echocardiography to assess the right ventricle, an important parameter to select the patients with severe TR who may benefit from intervention. Finally, the use of 3D echocardiography during the guidance of transcatheter interventions is pivotal to ensure procedural success and minimize the complications. Three-dimensional echocardiography provides the soft tissue resolution that fluoroscopy does not provide.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3-Dimensional echocardiography; Right ventricle; Transcatheter tricuspid valve interventions; Tricuspid regurgitation

Year:  2022        PMID: 36048305     DOI: 10.1007/s11886-022-01780-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   3.955


  18 in total

Review 1.  3-Dimensional Echocardiography in Imaging the Tricuspid Valve.

Authors:  Denisa Muraru; Rebecca T Hahn; Osama I Soliman; Francesco F Faletra; Cristina Basso; Luigi P Badano
Journal:  JACC Cardiovasc Imaging       Date:  2019-03

2.  New Directions in Right Ventricular Assessment Using 3-Dimensional Echocardiography.

Authors:  Karima Addetia; Denisa Muraru; Luigi P Badano; Roberto M Lang
Journal:  JAMA Cardiol       Date:  2019-09-01       Impact factor: 14.676

Review 3.  Three-dimensional echocardiography for the assessment of the tricuspid valve.

Authors:  Andrew C Peters; Fei Fei Gong; Vera H Rigolin
Journal:  Echocardiography       Date:  2020-04-21       Impact factor: 1.724

4.  Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature.

Authors:  Rebecca T Hahn; Ludwig T Weckbach; Thilo Noack; Nadira Hamid; Mitsunobu Kitamura; Richard Bae; Philipp Lurz; Susheel K Kodali; Paul Sorajja; Jörg Hausleiter; Michael Nabauer
Journal:  JACC Cardiovasc Imaging       Date:  2021-03-17

Review 5.  Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications.

Authors:  Edgard A Prihadi; Victoria Delgado; Martin B Leon; Maurice Enriquez-Sarano; Yan Topilsky; Jeroen J Bax
Journal:  JACC Cardiovasc Imaging       Date:  2019-03

6.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

7.  Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history.

Authors:  Edgard A Prihadi; Pieter van der Bijl; Erhan Gursoy; Rachid Abou; E Mara Vollema; Rebecca T Hahn; Gregg W Stone; Martin B Leon; Nina Ajmone Marsan; Victoria Delgado; Jeroen J Bax
Journal:  Eur Heart J       Date:  2018-10-14       Impact factor: 29.983

Review 8.  Diagnosis and treatment of tricuspid valve disease: current and future perspectives.

Authors:  Josep Rodés-Cabau; Maurizio Taramasso; Patrick T O'Gara
Journal:  Lancet       Date:  2016-04-02       Impact factor: 79.321

9.  3D printing of normal and pathologic tricuspid valves from transthoracic 3D echocardiography data sets.

Authors:  Denisa Muraru; Federico Veronesi; Anna Maddalozzo; Daniele Dequal; Leonardo Frajhof; Arnaldo Rabischoffsky; Sabino Iliceto; Luigi P Badano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-07-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.